0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cetirizine Hydrochloride Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-23A4072
Home | Market Reports
Global Cetirizine Hydrochloride Market Research Report 2021
BUY CHAPTERS

Global Cetirizine Hydrochloride Market Research Report 2026

Code: QYRE-Auto-23A4072
Report
2026-02-06
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cetirizine Hydrochloride Market Size

The global Cetirizine Hydrochloride market was valued at US$ 1127 million in 2025 and is anticipated to reach US$ 1512 million by 2032, at a CAGR of 4.4% from 2026 to 2032.

Cetirizine Hydrochloride Market

Cetirizine Hydrochloride Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cetirizine Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cetirizine Hydrochloride is a second-generation, non-sedating antihistamine used primarily to treat and alleviate allergic disease symptoms such as seasonal or perennial rhinitis, urticaria, allergic conjunctivitis, etc. It works by selectively antagonizing the histamine H₁ receptor to reduce sneezing, runny nose, itching, and eye inflammation. Compared with first-generation antihistamines, cetirizine has lower central nervous system sedation, better tolerability, and more convenient dosage forms, including oral tablets, syrups, immediate-release or sustained-release formulations. In the global pharmaceutical market, it straddles both prescription and OTC status in many countries or is under consideration for switching to OTC, due to its favorable safety profile, mature clinical usage, and strong brand awareness, making it one of the indispensable agents in allergy treatment.In 2024, global Cetirizine Hydrochloride production reached approximately 717.33 m units, with an average global market price of around US$ 1.5 perunit.
With global environmental changes, worsening air pollution, accelerating urbanization, and climate variability, the incidence of allergic diseases—such as rhinitis, urticaria, and allergic conjunctivitis—is steadily rising, providing a large natural demand base for second-generation antihistamines like cetirizine. In addition, the enhanced self-care awareness among consumers drives demand for fast, safe relief options, increasing the appeal of OTC medicines. Regulatory reforms in many countries—simplifying drug registration, facilitating prescription-to-OTC switches, improving drug accessibility—provide breakthrough opportunities for cetirizine to expand its market channels and reach. Furthermore, advances in formulation and pharmaceutical technologies (e.g., immediate-release vs sustained-release tablets, liquid forms, pediatric-friendly formulations) make differentiation possible, improving patient adherence and experience and enhancing brand competitiveness. Also, pharmaceutical companies expanding into emerging markets (especially in Asia, Latin America, Middle East & Africa) where healthcare coverage is improving, consumer purchasing power is rising, and distribution networks are modernizing, which strongly drives product penetration and volume growth.
Despite its strong potential, the cetirizine industry faces several challenges and risks. First, substitution pressure from other second-generation antihistamines (e.g., loratadine, desloratadine, levocetirizine, etc.) and newer allergy treatments is increasing; in a competitive price and generic market, product differentiation and brand loyalty become critical. Second, though overall safety is good, long-term use may reveal adverse reactions, drug-drug interactions, or significant inter-individual variability (e.g., potential sedation, liver function impact, etc.), creating possible regulatory or market concerns. Third, regulatory uncertainty remains: drug approval processes, prescription vs non-prescription switching policies, quality standards, GMP/ICH standards, and registration requirements vary across regions and can change, increasing market entry hurdles and compliance costs. Fourth, risks in raw material supply, production cost, and supply chain stability are material, including volatility in intermediate and reagent prices, stricter environmental policy and safety production standards for chemical plants, and potential trade barriers or tariffs that add costs or delays.
Demand in the downstream (finished pharmaceutical + end-use) market shows the following trends: First, expansion of OTC channels is prominent; as consumers increasingly self-diagnose and self-treat mild to moderate allergy symptoms, the proportion of cetirizine sold OTC rises. Second, the pediatric and elderly segments are growing significantly; these populations require higher safety, better tolerability, and dosage forms adapted to swallowing, taste, flexibility of dosing—leading to demand for syrups, chewable/dispersible tablets, small-dose/pediatric doses, etc. Third, there is increasing demand for combination therapies or adjunctive treatments—e.g. pairing oral antihistamines with anti-inflammatories, or using nasal sprays etc.—to address multi-symptom allergies. Fourth, e-commerce and digital health platforms (symptom tracking apps, telemedicine, online pharmacies) have growing influence on consumer behavior, pushing brands to invest in packaging, digital marketing, supply-chain efficiency, and online convenience.
Cetirizine’s API upstream relies on key chemical intermediates and reagents—such as substituted aromatic chloroderivatives (e.g. p-chlorobenzaldehyde or chlorinated benzene derivatives), aminated or hydroxylated intermediates, and reagents for protection/deprotection, oxidation/reduction, and catalytic steps. Chemical reagent suppliers, solvent and catalytic systems play a key role. Many of these intermediate producers are based in China, India, and other cost-advantaged chemical manufacturing hubs. Components of cost include solvents, catalysts (sometimes precious‐metal or specialty catalysts), purification reagents, energy, plus downstream costs of crystalline form, purity, residual solvents. Environmental, safety, and regulatory policies significantly affect these upstream segments: emission controls, hazardous chemical regulations, waste treatment, certifying raw material suppliers under GMP or equivalent systems; failure in any of these can lead to supply disruptions or cost spikes. Some Chinese API manufacturers (e.g. Hunan Jiudian Pharma) already have scale, international certifications, and strong capability in cost control and process R&D, which strengthen upstream resilience and competitive advantage.The average gross profit margin in the industry is 35-50%.
This report delivers a comprehensive overview of the global Cetirizine Hydrochloride market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cetirizine Hydrochloride. The Cetirizine Hydrochloride market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cetirizine Hydrochloride market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cetirizine Hydrochloride manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cetirizine Hydrochloride Market Report

Report Metric Details
Report Name Cetirizine Hydrochloride Market
Accounted market size in 2025 US$ 1127 million
Forecasted market size in 2032 US$ 1512 million
CAGR 4.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Tablet
  • Capsule
  • Solution
by Application
  • Hospital
  • Drug Store
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kenvue, UCB Pharma, GSK, Teva, Qilu Pharma, Sun Pharma, Hunan Jiudian Pharm, Lunan Pharma, Viatris, Apotex, Jubilant Life Sciences, HAILISHENG, Sandoz, Dr Reddy's, Tabuk Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cetirizine Hydrochloride manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cetirizine Hydrochloride sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Cetirizine Hydrochloride Market growing?

Ans: The Cetirizine Hydrochloride Market witnessing a CAGR of 4.4% during the forecast period 2026-2032.

What is the Cetirizine Hydrochloride Market size in 2032?

Ans: The Cetirizine Hydrochloride Market size in 2032 will be US$ 1512 million.

Who are the main players in the Cetirizine Hydrochloride Market report?

Ans: The main players in the Cetirizine Hydrochloride Market are Kenvue, UCB Pharma, GSK, Teva, Qilu Pharma, Sun Pharma, Hunan Jiudian Pharm, Lunan Pharma, Viatris, Apotex, Jubilant Life Sciences, HAILISHENG, Sandoz, Dr Reddy's, Tabuk Pharma

What are the Application segmentation covered in the Cetirizine Hydrochloride Market report?

Ans: The Applications covered in the Cetirizine Hydrochloride Market report are Hospital, Drug Store, Others

What are the Type segmentation covered in the Cetirizine Hydrochloride Market report?

Ans: The Types covered in the Cetirizine Hydrochloride Market report are Tablet, Capsule, Solution

1 Cetirizine Hydrochloride Market Overview
1.1 Product Definition
1.2 Cetirizine Hydrochloride by Type
1.2.1 Global Cetirizine Hydrochloride Market Value by Type: 2025 vs 2032
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Solution
1.3 Cetirizine Hydrochloride by Application
1.3.1 Global Cetirizine Hydrochloride Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Global Cetirizine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Cetirizine Hydrochloride Revenue 2021–2032
1.4.2 Global Cetirizine Hydrochloride Sales 2021–2032
1.4.3 Global Cetirizine Hydrochloride Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cetirizine Hydrochloride Market Competition by Manufacturers
2.1 Global Cetirizine Hydrochloride Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cetirizine Hydrochloride Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cetirizine Hydrochloride Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cetirizine Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cetirizine Hydrochloride, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cetirizine Hydrochloride, Product Types and Applications
2.7 Global Key Manufacturers of Cetirizine Hydrochloride, Date of Entry into the Industry
2.8 Global Cetirizine Hydrochloride Market Competitive Situation and Trends
2.8.1 Global Cetirizine Hydrochloride Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cetirizine Hydrochloride Players Market Share by Revenue
2.8.3 Global Cetirizine Hydrochloride Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cetirizine Hydrochloride Market Scenario by Region
3.1 Global Cetirizine Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cetirizine Hydrochloride Sales by Region: 2021–2032
3.2.1 Global Cetirizine Hydrochloride Sales by Region: 2021–2026
3.2.2 Global Cetirizine Hydrochloride Sales by Region: 2027–2032
3.3 Global Cetirizine Hydrochloride Revenue by Region: 2021–2032
3.3.1 Global Cetirizine Hydrochloride Revenue by Region: 2021–2026
3.3.2 Global Cetirizine Hydrochloride Revenue by Region: 2027–2032
3.4 North America Cetirizine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Cetirizine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cetirizine Hydrochloride Sales by Country (2021–2032)
3.4.3 North America Cetirizine Hydrochloride Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cetirizine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Cetirizine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cetirizine Hydrochloride Sales by Country (2021–2032)
3.5.3 Europe Cetirizine Hydrochloride Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cetirizine Hydrochloride Market Facts & Figures by Region
3.6.1 Asia Pacific Cetirizine Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cetirizine Hydrochloride Sales by Region (2021–2032)
3.6.3 Asia Pacific Cetirizine Hydrochloride Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cetirizine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Cetirizine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cetirizine Hydrochloride Sales by Country (2021–2032)
3.7.3 Latin America Cetirizine Hydrochloride Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cetirizine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Cetirizine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cetirizine Hydrochloride Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cetirizine Hydrochloride Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cetirizine Hydrochloride Sales by Type (2021–2032)
4.1.1 Global Cetirizine Hydrochloride Sales by Type (2021–2026)
4.1.2 Global Cetirizine Hydrochloride Sales by Type (2027–2032)
4.1.3 Global Cetirizine Hydrochloride Sales Market Share by Type (2021–2032)
4.2 Global Cetirizine Hydrochloride Revenue by Type (2021–2032)
4.2.1 Global Cetirizine Hydrochloride Revenue by Type (2021–2026)
4.2.2 Global Cetirizine Hydrochloride Revenue by Type (2027–2032)
4.2.3 Global Cetirizine Hydrochloride Revenue Market Share by Type (2021–2032)
4.3 Global Cetirizine Hydrochloride Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cetirizine Hydrochloride Sales by Application (2021–2032)
5.1.1 Global Cetirizine Hydrochloride Sales by Application (2021–2026)
5.1.2 Global Cetirizine Hydrochloride Sales by Application (2027–2032)
5.1.3 Global Cetirizine Hydrochloride Sales Market Share by Application (2021–2032)
5.2 Global Cetirizine Hydrochloride Revenue by Application (2021–2032)
5.2.1 Global Cetirizine Hydrochloride Revenue by Application (2021–2026)
5.2.2 Global Cetirizine Hydrochloride Revenue by Application (2027–2032)
5.2.3 Global Cetirizine Hydrochloride Revenue Market Share by Application (2021–2032)
5.3 Global Cetirizine Hydrochloride Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Kenvue
6.1.1 Kenvue Company Information
6.1.2 Kenvue Description and Business Overview
6.1.3 Kenvue Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Kenvue Cetirizine Hydrochloride Product Portfolio
6.1.5 Kenvue Recent Developments/Updates
6.2 UCB Pharma
6.2.1 UCB Pharma Company Information
6.2.2 UCB Pharma Description and Business Overview
6.2.3 UCB Pharma Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 UCB Pharma Cetirizine Hydrochloride Product Portfolio
6.2.5 UCB Pharma Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GSK Cetirizine Hydrochloride Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Cetirizine Hydrochloride Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Qilu Pharma
6.5.1 Qilu Pharma Company Information
6.5.2 Qilu Pharma Description and Business Overview
6.5.3 Qilu Pharma Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qilu Pharma Cetirizine Hydrochloride Product Portfolio
6.5.5 Qilu Pharma Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Company Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharma Cetirizine Hydrochloride Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Hunan Jiudian Pharm
6.7.1 Hunan Jiudian Pharm Company Information
6.7.2 Hunan Jiudian Pharm Description and Business Overview
6.7.3 Hunan Jiudian Pharm Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hunan Jiudian Pharm Cetirizine Hydrochloride Product Portfolio
6.7.5 Hunan Jiudian Pharm Recent Developments/Updates
6.8 Lunan Pharma
6.8.1 Lunan Pharma Company Information
6.8.2 Lunan Pharma Description and Business Overview
6.8.3 Lunan Pharma Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lunan Pharma Cetirizine Hydrochloride Product Portfolio
6.8.5 Lunan Pharma Recent Developments/Updates
6.9 Viatris
6.9.1 Viatris Company Information
6.9.2 Viatris Description and Business Overview
6.9.3 Viatris Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Viatris Cetirizine Hydrochloride Product Portfolio
6.9.5 Viatris Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Apotex Cetirizine Hydrochloride Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Jubilant Life Sciences
6.11.1 Jubilant Life Sciences Company Information
6.11.2 Jubilant Life Sciences Description and Business Overview
6.11.3 Jubilant Life Sciences Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jubilant Life Sciences Cetirizine Hydrochloride Product Portfolio
6.11.5 Jubilant Life Sciences Recent Developments/Updates
6.12 HAILISHENG
6.12.1 HAILISHENG Company Information
6.12.2 HAILISHENG Description and Business Overview
6.12.3 HAILISHENG Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 HAILISHENG Cetirizine Hydrochloride Product Portfolio
6.12.5 HAILISHENG Recent Developments/Updates
6.13 Sandoz
6.13.1 Sandoz Company Information
6.13.2 Sandoz Description and Business Overview
6.13.3 Sandoz Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sandoz Cetirizine Hydrochloride Product Portfolio
6.13.5 Sandoz Recent Developments/Updates
6.14 Dr Reddy's
6.14.1 Dr Reddy's Company Information
6.14.2 Dr Reddy's Description and Business Overview
6.14.3 Dr Reddy's Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Dr Reddy's Cetirizine Hydrochloride Product Portfolio
6.14.5 Dr Reddy's Recent Developments/Updates
6.15 Tabuk Pharma
6.15.1 Tabuk Pharma Company Information
6.15.2 Tabuk Pharma Description and Business Overview
6.15.3 Tabuk Pharma Cetirizine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Tabuk Pharma Cetirizine Hydrochloride Product Portfolio
6.15.5 Tabuk Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cetirizine Hydrochloride Industry Chain Analysis
7.2 Cetirizine Hydrochloride Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cetirizine Hydrochloride Production Mode & Process Analysis
7.4 Cetirizine Hydrochloride Sales and Marketing
7.4.1 Cetirizine Hydrochloride Sales Channels
7.4.2 Cetirizine Hydrochloride Distributors
7.5 Cetirizine Hydrochloride Customer Analysis
8 Cetirizine Hydrochloride Market Dynamics
8.1 Cetirizine Hydrochloride Industry Trends
8.2 Cetirizine Hydrochloride Market Drivers
8.3 Cetirizine Hydrochloride Market Challenges
8.4 Cetirizine Hydrochloride Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cetirizine Hydrochloride Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cetirizine Hydrochloride Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cetirizine Hydrochloride Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cetirizine Hydrochloride Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Cetirizine Hydrochloride Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cetirizine Hydrochloride Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cetirizine Hydrochloride Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cetirizine Hydrochloride Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cetirizine Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cetirizine Hydrochloride, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cetirizine Hydrochloride, Product Types and Applications
 Table 12. Global Key Manufacturers of Cetirizine Hydrochloride, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cetirizine Hydrochloride Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cetirizine Hydrochloride Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cetirizine Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cetirizine Hydrochloride Sales by Region (K Units), 2021–2026
 Table 18. Global Cetirizine Hydrochloride Sales Market Share by Region (2021–2026)
 Table 19. Global Cetirizine Hydrochloride Sales by Region (K Units), 2027–2032
 Table 20. Global Cetirizine Hydrochloride Sales Market Share by Region (2027–2032)
 Table 21. Global Cetirizine Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cetirizine Hydrochloride Revenue Market Share by Region (2021–2026)
 Table 23. Global Cetirizine Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cetirizine Hydrochloride Revenue Market Share by Region (2027–2032)
 Table 25. North America Cetirizine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cetirizine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 27. North America Cetirizine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 28. North America Cetirizine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cetirizine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cetirizine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cetirizine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 32. Europe Cetirizine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 33. Europe Cetirizine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cetirizine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cetirizine Hydrochloride Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cetirizine Hydrochloride Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Cetirizine Hydrochloride Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Cetirizine Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cetirizine Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cetirizine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cetirizine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 42. Latin America Cetirizine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 43. Latin America Cetirizine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cetirizine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cetirizine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cetirizine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Cetirizine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Cetirizine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cetirizine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cetirizine Hydrochloride Sales (K Units) by Type (2021–2026)
 Table 51. Global Cetirizine Hydrochloride Sales (K Units) by Type (2027–2032)
 Table 52. Global Cetirizine Hydrochloride Sales Market Share by Type (2021–2026)
 Table 53. Global Cetirizine Hydrochloride Sales Market Share by Type (2027–2032)
 Table 54. Global Cetirizine Hydrochloride Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cetirizine Hydrochloride Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cetirizine Hydrochloride Revenue Market Share by Type (2021–2026)
 Table 57. Global Cetirizine Hydrochloride Revenue Market Share by Type (2027–2032)
 Table 58. Global Cetirizine Hydrochloride Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Cetirizine Hydrochloride Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Cetirizine Hydrochloride Sales (K Units) by Application (2021–2026)
 Table 61. Global Cetirizine Hydrochloride Sales (K Units) by Application (2027–2032)
 Table 62. Global Cetirizine Hydrochloride Sales Market Share by Application (2021–2026)
 Table 63. Global Cetirizine Hydrochloride Sales Market Share by Application (2027–2032)
 Table 64. Global Cetirizine Hydrochloride Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cetirizine Hydrochloride Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cetirizine Hydrochloride Revenue Market Share by Application (2021–2026)
 Table 67. Global Cetirizine Hydrochloride Revenue Market Share by Application (2027–2032)
 Table 68. Global Cetirizine Hydrochloride Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Cetirizine Hydrochloride Price (USD/Unit) by Application (2027–2032)
 Table 70. Kenvue Company Information
 Table 71. Kenvue Description and Business Overview
 Table 72. Kenvue Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Kenvue Cetirizine Hydrochloride Product
 Table 74. Kenvue Recent Developments/Updates
 Table 75. UCB Pharma Company Information
 Table 76. UCB Pharma Description and Business Overview
 Table 77. UCB Pharma Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. UCB Pharma Cetirizine Hydrochloride Product
 Table 79. UCB Pharma Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. GSK Cetirizine Hydrochloride Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Teva Cetirizine Hydrochloride Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Qilu Pharma Company Information
 Table 91. Qilu Pharma Description and Business Overview
 Table 92. Qilu Pharma Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Qilu Pharma Cetirizine Hydrochloride Product
 Table 94. Qilu Pharma Recent Developments/Updates
 Table 95. Sun Pharma Company Information
 Table 96. Sun Pharma Description and Business Overview
 Table 97. Sun Pharma Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Sun Pharma Cetirizine Hydrochloride Product
 Table 99. Sun Pharma Recent Developments/Updates
 Table 100. Hunan Jiudian Pharm Company Information
 Table 101. Hunan Jiudian Pharm Description and Business Overview
 Table 102. Hunan Jiudian Pharm Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Hunan Jiudian Pharm Cetirizine Hydrochloride Product
 Table 104. Hunan Jiudian Pharm Recent Developments/Updates
 Table 105. Lunan Pharma Company Information
 Table 106. Lunan Pharma Description and Business Overview
 Table 107. Lunan Pharma Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Lunan Pharma Cetirizine Hydrochloride Product
 Table 109. Lunan Pharma Recent Developments/Updates
 Table 110. Viatris Company Information
 Table 111. Viatris Description and Business Overview
 Table 112. Viatris Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Viatris Cetirizine Hydrochloride Product
 Table 114. Viatris Recent Developments/Updates
 Table 115. Apotex Company Information
 Table 116. Apotex Description and Business Overview
 Table 117. Apotex Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Apotex Cetirizine Hydrochloride Product
 Table 119. Apotex Recent Developments/Updates
 Table 120. Jubilant Life Sciences Company Information
 Table 121. Jubilant Life Sciences Description and Business Overview
 Table 122. Jubilant Life Sciences Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Jubilant Life Sciences Cetirizine Hydrochloride Product
 Table 124. Jubilant Life Sciences Recent Developments/Updates
 Table 125. HAILISHENG Company Information
 Table 126. HAILISHENG Description and Business Overview
 Table 127. HAILISHENG Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. HAILISHENG Cetirizine Hydrochloride Product
 Table 129. HAILISHENG Recent Developments/Updates
 Table 130. Sandoz Company Information
 Table 131. Sandoz Description and Business Overview
 Table 132. Sandoz Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Sandoz Cetirizine Hydrochloride Product
 Table 134. Sandoz Recent Developments/Updates
 Table 135. Dr Reddy's Company Information
 Table 136. Dr Reddy's Description and Business Overview
 Table 137. Dr Reddy's Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Dr Reddy's Cetirizine Hydrochloride Product
 Table 139. Dr Reddy's Recent Developments/Updates
 Table 140. Tabuk Pharma Company Information
 Table 141. Tabuk Pharma Description and Business Overview
 Table 142. Tabuk Pharma Cetirizine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Tabuk Pharma Cetirizine Hydrochloride Product
 Table 144. Tabuk Pharma Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Cetirizine Hydrochloride Distributors List
 Table 148. Cetirizine Hydrochloride Customers List
 Table 149. Cetirizine Hydrochloride Market Trends
 Table 150. Cetirizine Hydrochloride Market Drivers
 Table 151. Cetirizine Hydrochloride Market Challenges
 Table 152. Cetirizine Hydrochloride Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cetirizine Hydrochloride
 Figure 2. Global Cetirizine Hydrochloride Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cetirizine Hydrochloride Market Share by Type: 2025 & 2032
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Solution Product Picture
 Figure 7. Global Cetirizine Hydrochloride Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Cetirizine Hydrochloride Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Drug Store
 Figure 11. Others
 Figure 12. Global Cetirizine Hydrochloride Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Cetirizine Hydrochloride Market Size (US$ Million), 2021–2032
 Figure 14. Global Cetirizine Hydrochloride Sales (K Units), 2021–2032
 Figure 15. Global Cetirizine Hydrochloride Average Price (USD/Unit), 2021–2032
 Figure 16. Cetirizine Hydrochloride Report Years Considered
 Figure 17. Cetirizine Hydrochloride Sales Share by Manufacturers in 2025
 Figure 18. Global Cetirizine Hydrochloride Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Cetirizine Hydrochloride Players: Market Share by Revenue in Cetirizine Hydrochloride in 2025
 Figure 20. Cetirizine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Cetirizine Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Cetirizine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 23. North America Cetirizine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Cetirizine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 27. Europe Cetirizine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Cetirizine Hydrochloride Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Cetirizine Hydrochloride Revenue Market Share by Region (2021–2032)
 Figure 35. China Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Cetirizine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Cetirizine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Cetirizine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Cetirizine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. U.A.E Cetirizine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Cetirizine Hydrochloride by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Cetirizine Hydrochloride by Type (2021–2032)
 Figure 57. Global Cetirizine Hydrochloride Price (USD/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Cetirizine Hydrochloride by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Cetirizine Hydrochloride by Application (2021–2032)
 Figure 60. Global Cetirizine Hydrochloride Price (USD/Unit) by Application (2021–2032)
 Figure 61. Cetirizine Hydrochloride Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners